statements

Kerala Ayurveda Ltd.

BSE: 530163

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

178.95-1.2 (-0.67%)

3 Jul, 3:30 PM

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

Kerala Ayurveda Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	C 2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M IR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Total Revenue	34.26	31.24	34.85	39.03	45.95	53.92	58.87	59.03	76.77	62.07	80.35	93.41	107.86	120.33	131.15
Cost of Operating Revenue	12.72	9.07	7.27	8.99	11.58	12.84	13.11	14.57	16.10	16.26	18.37	21.16	23.30	36.39	33.07
Gross Profit	21.54	22.16	27.58	30.04	34.37	41.08	45.76	44.46	60.67	45.81	61.98	72.26	84.56	83.94	98.07
Gross Margin	62.9	71.0	79.1	77.0	74.8	76.2	77.7	75.3	79.0	73.8	77.1	77.4	78.4	69.8	74.8
Total Operating Expenses	35.52	30.42	32.69	34.26	40.80	48.53	52.16	54.95	69.80	62.60	72.17	88.78	100.92	130.30	154.38
Operating Profit	-1.26	0.82	2.16	4.77	5.14	5.39	6.71	4.08	6.97	-0.53	8.18	4.64	6.93	-9.97	-23.24
Operating Margin	-3.7	2.6	6.2	12.2	11.2	10.0	11.4	6.9	9.1	-0.9	10.2	5.0	6.4	-8.3	-17.7
Financing Income/(Expense) - Net	-0.64	-0.85	-0.62	-1.59	-1.11	-1.36	-2.81	-2.43	-2.46	-6.29	-6.52	-8.32	-6.18	-1.90	-7.34
Profit before Taxes	-1.90	0.16	1.75	3.17	4.11	4.18	4.17	3.10	4.54	-6.74	2.80	-0.56	1.27	-12.24	-16.36
Income Taxes	0.18	0.66	0.83	0.66	1.37	0.90	1.29	0.57	0.48	-1.89	0.41	-0.13	2.13	1.72	-0.04
Profit after Tax	-2.14	-0.61	0.74	2.36	2.70	3.06	2.81	2.44	3.90	-4.84	2.36	-0.90	-1.53	-13.96	-16.56
PAT Margin	-6.3	-1.9	2.1	6.0	5.9	5.7	4.8	4.1	5.1	-7.8	2.9	-1.0	-1.4	-11.6	-12.6
EPS - Basic - ex Extraordinary Items	-2.03	-0.58	0.70	2.23	2.56	2.90	2.66	2.32	3.69	-4.59	2.24	-0.85	-1.38	-11.60	-13.53
EPS - Diluted - ex Extraordinary Items	-2.03	-0.58	0.70	2.23	2.56	2.90	2.66	2.32	3.69	-4.59	2.24	-0.85	-1.38	-11.60	-13.53
EBIT	-1.26	0.82	2.16	4.77	5.14	5.39	6.71	4.08	6.97	-0.53	8.18	4.64	6.93	-9.97	-23.24
EBITDA	0.62	2.82	3.25	5.91	7.13	7.17	8.54	5.06	8.12	0.75	9.38	5.74	8.28	-4.99	-17.75
EBITDA Margin	1.8	9.0	9.3	15.1	15.5	13.3	14.5	8.6	10.6	1.2	11.7	6.1	7.7	-4.1	-13.5

Balance Sheet

Abridged

Understanding Balance Sheet

Kerala Ayurveda Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	C 2013 Mar 31	2014 Mar 31	2015 Mar 31	C 2016 Mar 31	C 2017 Mar 31	2018 Mar 31	C 2019 Mar 31	2020 Mar 31	2021 Mar 31	R 2022 Mar 31	R 2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	IR	AR	AR	PRESS
Total Current Assets	7.72	9.12	9.43	13.75	16.72	21.75	42.03	28.29	32.97	43.65	37.15	35.25	60.09	40.77	46.92
Long-Term Investments	0.10	0.10	0.10	0.13	1.42	1.58	1.67	1.67	4.56	4.49	6.13	6.73	7.17	0.05	4.16
Property Plant & Equipment - Net	19.72	23.66	24.03	22.34	29.24	28.98	32.78	34.30	36.11	35.94	26.10	30.84	30.72	40.28	40.55
Total Non-Current Assets	40.96	53.62	56.66	58.59	56.36	58.28	60.52	63.69	69.30	70.19	73.17	80.65	80.62	87.99	91.51
Total Assets	49.55	63.09	66.40	72.58	73.25	80.55	102.93	92.29	102.97	114.49	110.32	115.90	140.71	128.76	138.42
Total Current Liabilities	12.13	13.06	22.65	25.36	44.50	48.11	45.41	27.59	30.59	34.34	60.36	52.69	40.40	87.97	99.42
Long Term Debt	46.23	59.03	51.68	53.74	19.06	20.17	42.85	49.77	52.44	66.08	37.21	50.42	59.42	22.22	17.99
Total Non-Current Liabilities	47.04	61.05	54.03	56.13	22.34	23.98	48.05	59.33	62.65	74.94	42.01	55.33	65.17	27.90	24.12
Total Liabilities	59.17	74.11	76.68	81.49	66.84	72.08	93.46	86.92	93.24	109.28	102.37	108.02	105.57	115.87	123.54
Total Shareholders' Equity	-10.41	-11.02	-10.28	-8.91	5.13	6.97	7.90	3.73	7.92	3.40	6.11	5.58	32.16	9.49	11.12
Minority Interest	0.79	-	-	-	1.27	1.49	1.57	1.64	1.80	1.80	1.83	2.30	2.97	3.40	3.77
Total Equity	-9.62	-11.02	-10.28	-8.91	6.41	8.46	9.47	5.37	9.73	5.20	7.94	7.88	35.13	12.89	14.89
Total Liabilities & Equity	49.55	63.09	66.40	72.58	73.25	80.55	102.93	92.29	102.97	114.49	110.32	115.90	140.71	128.76	138.42

Cash Flow

Abridged

Understanding Cash Flow Statement

Kerala Ayurveda Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	R 2013 Mar 31	2014 Mar 31	2015 Mar 31	C 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	R 2022 Mar 31	R 2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M IR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	-1.02	1.64	2.17	3.99	6.09	4.53	3.65	-4.62	5.77	-5.14	4.35	0.87	1.31	-4.53	-10.89
Working Capital - Increase/(Decrease)	9.22	-10.45	-3.46	-5.56	-1.78	-1.26	-15.39	14.61	-2.31	6.28	-11.12	4.24	-3.58	5.24	-14.61
Net CF from Operating Activities	8.21	-8.81	-1.29	-1.57	4.31	3.27	-11.74	9.99	3.46	1.14	-6.77	5.11	-2.27	0.71	-25.49
Capital Expenditures - Net	0.73	3.92	1.13	0.35	3.27	1.81	5.48	2.40	3.35	1.04	2.85	6.11	1.08	13.32	5.62
Net CF from Investing Activities	-0.77	-3.83	-1.13	-0.37	-3.27	-3.49	-3.33	-3.03	-4.05	-1.47	-2.16	-7.29	-1.42	-14.73	-5.49
Stock - Issuance/(Retirement) - Net	-	-	-	-	-	-	-	-	-	-	-	-	28.15	-	0.03
Debt - LT & ST - Issuance/(Retirement) - Total	-9.96	12.45	1.90	3.75	-1.13	1.35	18.71	-9.12	2.40	12.53	-6.75	3.69	-6.05	-5.40	33.73
Net Cash Flow from Financing Activities	-9.96	12.45	1.90	3.75	-1.13	1.35	18.71	-9.12	2.40	12.53	-6.75	3.69	22.10	-5.40	33.76
Free Cash Flow to Equity	-2.49	-0.28	-0.53	1.84	-0.09	2.82	1.49	-1.54	2.51	12.62	-16.37	2.69	-9.39	-18.01	2.62
Free Operating CF net dividend	7.48	-12.93	-2.63	-1.94	1.03	1.39	-17.23	7.53	0.11	0.10	-9.62	-1.07	-3.38	-12.62	-31.11
Free Operating CF	7.48	-12.93	-2.63	-1.94	1.03	1.39	-17.23	7.53	0.11	0.10	-9.62	-1.07	-3.38	-12.62	-31.11

Business Segment Analysis

FY End:

Mar 25

Kerala Ayurveda Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Ayurveda Services (100.0%)₹ 13.33 Cr

Revenue / Sales

Ayurveda Services (100.0%)₹ 120.33 Cr

Assets

Ayurveda Services (100.0%)₹ 128.76 Cr

Operating Income

Ayurveda Services (100.0%)₹ -9.97 Cr

Regional Segment Analysis

Kerala Ayurveda Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Kerala Ayurveda Ltd.

Historical Segment Analysis

Track how Kerala Ayurveda Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2025 Mar 31

Ayurveda Services	13

Frequently Asked Questions

What is the revenue of Kerala Ayurveda Ltd.?

The latest trailing twelve month revenue of Kerala Ayurveda Ltd. is ₹ 131.15 Cr, reflecting a 1-year growth of 8.98% and a 3-year CAGR of 11.97%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Kerala Ayurveda Ltd.?

The latest trailing twelve month net profit (PAT) of Kerala Ayurveda Ltd. is ₹ -16.56 Cr, with a 3-year earnings CAGR of -151.25%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Kerala Ayurveda Ltd.?

The trailing twelve month EBITDA of Kerala Ayurveda Ltd. is approximately ₹ -23.24 Cr (based on an operating margin of -17.72%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Kerala Ayurveda Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Kerala Ayurveda Ltd. is -13.53. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Kerala Ayurveda Ltd.?

The debt-to-equity ratio of Kerala Ayurveda Ltd. stands at 7.77. The interest coverage ratio is -3.17x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Kerala Ayurveda Ltd.?

The estimated book value per share of Kerala Ayurveda Ltd. is 8.46 (derived from a P/B ratio of 21.14 and market price of ₹ 178.95), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Kerala Ayurveda Ltd.?

The trailing twelve month operating cash flow of Kerala Ayurveda Ltd. is ₹ -25.50 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Kerala Ayurveda Ltd. report consolidated or standalone financials?

Kerala Ayurveda Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.